Seres Therapeutics, Inc. (MCRB): 10-Q filed Nov 4, 2026

Form type

10-Q

Filing date

Nov 4, 2026

Accession number

0001193125-26-446427

Filer

Seres Therapeutics, Inc. (CIK 1609809)